Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy
Recruiting · NCT06850454 · Registry updated 2025-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Phase 3 | 2025-02-27 | NCT06850454 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mahidol University | 107 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Faculty of Medicine Siriraj Hospital, Mahidol University | Bangkok | Thailand | 3 |